Lepage V - Search Results

1

Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.

Khalil I, Deschamps I, Lepage V, al-Daccak R, Degos L, Hors J. Khalil I, et al. Among authors: lepage v. Diabetes. 1992 Mar;41(3):378-84. doi: 10.2337/diab.41.3.378. Diabetes. 1992. PMID: 1551498

2

Molecular approaches to the relationships between HLA and susceptibility to diseases.

Degos L, Khalil I, Blanchet O, Lepage V, Paul P, Hors J. Degos L, et al. Among authors: lepage v. Adv Nephrol Necker Hosp. 1992;21:13-22. Adv Nephrol Necker Hosp. 1992. PMID: 1566643 Review. No abstract available.

3

HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme.

Khalil I, Lepage V, Douay C, Morin L, al-Daccak R, Wallach D, Binet O, Lemarchand F, Degos L, Hors J. Khalil I, et al. Among authors: lepage v. J Invest Dermatol. 1991 Oct;97(4):697-700. doi: 10.1111/1523-1747.ep12484029. J Invest Dermatol. 1991. PMID: 1940441 Free article.

4

HLA DQ alpha/beta molecule associated with the susceptibility to insulin-dependent diabetes mellitus. A model for HLA/autoimmune disease association.

Khalil I, Deschamps I, Lepage V, Morin L, Galibert F, Degos L, Hors J. Khalil I, et al. Among authors: lepage v. Nouv Rev Fr Hematol (1978). 1990;32(6):445-7. Nouv Rev Fr Hematol (1978). 1990. PMID: 2101877

5

A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.

Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J. Khalil I, et al. Among authors: lepage v. J Clin Invest. 1990 Apr;85(4):1315-9. doi: 10.1172/JCI114569. J Clin Invest. 1990. PMID: 2318983 Free PMC article.

6

Typing for HLA DQ using oligonucleotidic probes.

Khalil I, d'Auriol L, Morin L, Gobet M, Lepage V, Galibert F, Degos L, Hors J. Khalil I, et al. Among authors: lepage v. Nouv Rev Fr Hematol (1978). 1990;32(1):109-12. Nouv Rev Fr Hematol (1978). 1990. PMID: 2349076

7

Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.

Khalil I, Berrih-Aknin S, Lepage V, Loste MN, Gajdos P, Hors J, Charron D, Degos L. Khalil I, et al. Among authors: lepage v. C R Acad Sci III. 1993 Jul;316(7):652-60. C R Acad Sci III. 1993. PMID: 8019886

8

HLA class II polymorphism and IDDM susceptibility in the Greek population.

Khalil I, Spyropoulou M, Mallet C, Loste MN, Douay C, Laperrière J, Bartzokas C, Lepage V, Charron D, Stavropoulos C. Khalil I, et al. Among authors: lepage v. Eur J Immunogenet. 1993 Jun;20(3):193-9. doi: 10.1111/j.1744-313x.1993.tb00110.x. Eur J Immunogenet. 1993. PMID: 8338816

9

Myasthenia gravis is associated with two DQ alpha/beta heterodimers.

Khalil I, Berrih-Aknin S, Lepage V, Lost MN, Gajdos P, Charron D, Hors J, Degos L. Khalil I, et al. Among authors: lepage v. Ann N Y Acad Sci. 1993 Jun 21;681:573-4. doi: 10.1111/j.1749-6632.1993.tb22944.x. Ann N Y Acad Sci. 1993. PMID: 8357201 No abstract available.

10

Local analysis of HLA class II monoclonal antibodies (mAb) proposed for prescreening for the 11th International Histocompatibility Workshop.

Lepage V, Khalil I, Douay C, Mallet C, Loste MN, Morin L, Hors J, Colombani J. Lepage V, et al. Tissue Antigens. 1991 Jan;37(1):44-8. doi: 10.1111/j.1399-0039.1991.tb01844.x. Tissue Antigens. 1991. PMID: 2063398 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters